Possible Statin-Parkinson’s Link To Be Explored In 16,000-Patient Study
This article was originally published in The Tan Sheet
Executive Summary
Researchers at the University of North Carolina plan a 16,000-patient cohort study to explore a possible link between statin use and Parkinson's disease, expanding on their recent study linking low LDL cholesterol with the condition
You may also be interested in...
Merck Regroups On Mevacor Switch; Could CUSTOM Analysis Pave The Way?
J&J/Merck is still pursuing an Rx-to-OTC switch of a 20 mg dose of the cholesterol-lowering therapy Mevacor (lovastatin), according to VP-Global Regulatory & Scientific Affairs Edwin Hemwall, PhD
Bayer Poised To “Seize Opportunities” After Rapid Integration Of Roche OTCs
Bayer will continue to pursue external as well as internal growth strategies for its OTC business following the rapid integration of Roche's OTC division
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers